IL84845A0 - Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof - Google Patents
Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereofInfo
- Publication number
- IL84845A0 IL84845A0 IL84845A IL8484587A IL84845A0 IL 84845 A0 IL84845 A0 IL 84845A0 IL 84845 A IL84845 A IL 84845A IL 8484587 A IL8484587 A IL 8484587A IL 84845 A0 IL84845 A0 IL 84845A0
- Authority
- IL
- Israel
- Prior art keywords
- salt
- certain
- pharmaceutical compositions
- carbazolone
- derivative
- Prior art date
Links
- AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical class C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868630075A GB8630075D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
| GB878726424A GB8726424D0 (en) | 1987-11-11 | 1987-11-11 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL84845A0 true IL84845A0 (en) | 1988-06-30 |
Family
ID=26291706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84845A IL84845A0 (en) | 1986-12-17 | 1987-12-16 | Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4845115A (pm) |
| EP (1) | EP0275668B1 (pm) |
| JP (1) | JP2608078B2 (pm) |
| KR (1) | KR950013450B1 (pm) |
| AU (1) | AU618520B2 (pm) |
| CY (1) | CY1692A (pm) |
| DE (1) | DE3782028T2 (pm) |
| DK (1) | DK662687A (pm) |
| ES (1) | ES2052585T3 (pm) |
| GR (1) | GR3006255T3 (pm) |
| HK (1) | HK36693A (pm) |
| IE (1) | IE60991B1 (pm) |
| IL (1) | IL84845A0 (pm) |
| NZ (1) | NZ222950A (pm) |
| PH (1) | PH25025A (pm) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
| US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
| GB8805269D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
| GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| US5229407A (en) * | 1988-09-01 | 1993-07-20 | Glaxo Group Limited | Medicaments |
| GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
| US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
| EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
| AU2295792A (en) * | 1991-06-26 | 1993-01-25 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| JPH06509073A (ja) * | 1991-06-26 | 1994-10-13 | セプラコア，インコーポレーテッド | 光学的に純粋なｓ（−）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物 |
| JPH08507514A (ja) * | 1993-03-08 | 1996-08-13 | 藤沢薬品工業株式会社 | 脳血管性疾患を治療または予防するための薬物 |
| ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
| WO2000040244A1 (en) * | 1999-01-07 | 2000-07-13 | P.N. Gerolymatos S.A. | Use of phanquinone for the treatment or prevention of memory impairment |
| CA2371822A1 (en) | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
| GB0701970D0 (en) | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
| US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
| FR2557110B1 (fr) * | 1983-12-23 | 1989-11-24 | Sandoz Sa | Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments |
| IT1182150B (it) * | 1984-01-25 | 1987-09-30 | Glaxo Group Ltd | Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono |
| AU583343B2 (en) * | 1985-01-23 | 1989-04-27 | Glaxo Group Limited | Heterocyclic compounds |
| US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
| EP0201165B1 (en) * | 1985-03-14 | 1994-07-20 | Beecham Group Plc | Medicaments for the treatment of emesis |
| US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| NL8701682A (nl) * | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
-
1987
- 1987-12-16 IL IL84845A patent/IL84845A0/xx not_active IP Right Cessation
- 1987-12-16 DK DK662687A patent/DK662687A/da not_active Application Discontinuation
- 1987-12-16 PH PH36242A patent/PH25025A/en unknown
- 1987-12-16 IE IE341487A patent/IE60991B1/en not_active IP Right Cessation
- 1987-12-16 EP EP87311078A patent/EP0275668B1/en not_active Expired - Lifetime
- 1987-12-16 JP JP62318456A patent/JP2608078B2/ja not_active Expired - Lifetime
- 1987-12-16 DE DE8787311078T patent/DE3782028T2/de not_active Expired - Lifetime
- 1987-12-16 ES ES87311078T patent/ES2052585T3/es not_active Expired - Lifetime
- 1987-12-16 US US07/133,884 patent/US4845115A/en not_active Expired - Lifetime
- 1987-12-16 NZ NZ222950A patent/NZ222950A/en unknown
- 1987-12-16 AU AU82614/87A patent/AU618520B2/en not_active Ceased
- 1987-12-17 KR KR1019870014391A patent/KR950013450B1/ko not_active Expired - Fee Related
-
1992
- 1992-11-16 GR GR920402595T patent/GR3006255T3/el unknown
-
1993
- 1993-04-15 HK HK366/93A patent/HK36693A/en not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169294A patent/CY1692A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0275668A2 (en) | 1988-07-27 |
| DK662687D0 (da) | 1987-12-16 |
| IE60991B1 (en) | 1994-09-07 |
| HK36693A (en) | 1993-04-23 |
| AU618520B2 (en) | 1992-01-02 |
| CY1692A (en) | 1994-01-14 |
| JPS63253083A (ja) | 1988-10-20 |
| US4845115A (en) | 1989-07-04 |
| GR3006255T3 (pm) | 1993-06-21 |
| DK662687A (da) | 1988-06-18 |
| NZ222950A (en) | 1997-06-24 |
| PH25025A (en) | 1991-01-28 |
| JP2608078B2 (ja) | 1997-05-07 |
| IE873414L (en) | 1988-06-17 |
| AU8261487A (en) | 1988-06-23 |
| KR950013450B1 (ko) | 1995-11-08 |
| ES2052585T3 (es) | 1994-07-16 |
| DE3782028D1 (de) | 1992-11-05 |
| EP0275668B1 (en) | 1992-09-30 |
| DE3782028T2 (de) | 1993-02-18 |
| KR880007074A (ko) | 1988-08-26 |
| EP0275668A3 (en) | 1989-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2222772B (en) | Pharmaceutical compositions | |
| GB2219940B (en) | Pharmaceutical compositions | |
| GB8710965D0 (en) | Pharmaceutical compositions | |
| IL84845A0 (en) | Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof | |
| EG18652A (en) | Pharmaceutical compositions | |
| HU896876D0 (en) | Pharmaceutical compositions | |
| GB8713091D0 (en) | Pharmaceutical compositions | |
| IL79195A0 (en) | Pharmaceutical compositions containing a styrylnaphthalene derivative | |
| IL79194A0 (en) | Pharmaceutical compositions containing a styrylnaphthalene derivative | |
| GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
| GB8830406D0 (en) | Pharmaceutical compositions | |
| IL84929A (en) | Pharmaceutical compositions comprising enkephalinase or derivatives thereof | |
| GB8809225D0 (en) | Pharmaceutical compositions | |
| GB8809840D0 (en) | Pharmaceutical compositions | |
| GB8830174D0 (en) | Pharmaceutical compositions | |
| GB8804189D0 (en) | Pharmaceutical compositions | |
| GB8829368D0 (en) | Pharmaceutical compositions | |
| GB8808117D0 (en) | Pharmaceutical compositions | |
| GB8822507D0 (en) | Pharmaceutical compositions | |
| GB8815443D0 (en) | Pharmaceutical compositions | |
| GB8808830D0 (en) | Pharmaceutical compositions | |
| IE882176L (en) | Pharmaceutical compositions | |
| GB8820265D0 (en) | Pharmaceutical compositions | |
| GB8815444D0 (en) | Pharmaceutical compositions | |
| ZA893224B (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |